TNYA — Tenaya Therapeutics Share News
0.000.00%
Brief: Tenaya Therapeutics Posts Q3 Loss Per Share Of $0.68
Tenaya Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Tenaya Therapeutics Q2 Loss Per Share $13.26
U.S. RESEARCH ROUNDUP- Immuneering, Matterport, Tenaya Therapeutics
Portfolio Company Update: Tenaya Therapeutics IPO
Brief: Tenaya Therapeutics Inc Shares Open 30% Above IPO Price In Nasdaq Debut
NASDAQ RESUMED AT 11:08 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:58 AM
NASDAQ RESUMED AT 09:58 AM
NASDAQ RESUMED AT 09:43 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 09:35 AM
NASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:01 AM
Brief: Tenaya Pricing Of Underwritten, Upsized IPO Of 12 Mln Shares Of Common Stock At $15.00 Per Share